Loading...
A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia–reperfusion injury
The cytokine erythropoietin (EPO) protects the heart from ischemic injury, in part by preventing apoptosis. However, EPO administration can also raise the hemoglobin concentration, which, by increasing oxygen delivery, confounds assignment of cause and effect. The availability of EPO analogs that do...
Saved in:
| Published in: | Proc Natl Acad Sci U S A |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
National Academy of Sciences
2005
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC548534/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15671158/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.0409329102 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|